• 1
    Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2001; 15: 34154.
  • 2
    Key TJ, Allen NE, Verkasalo PK, Banks E. Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 2001; 60: 819.
  • 3
    Dai D, Wolf DM, Litman ES, White MJ, Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 2002; 62: 8816.
  • 4
    Jasienska G, Thune I. Lifestyle, hormones, and risk of breast cancer. BMJ 2001; 322: 5867.
  • 5
    Levi F, Franceschi S, Negri E, La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer 1993; 71: 357581.
  • 6
    Zheng W, Kushi LH, Potter JD, Sellers TA, Doyle TJ, Bostick RM, Folsom AR. Dietary intake of energy and animal foods and endometrial cancer incidence: The Iowa Women's Health Study. Am J Epidemiol 1995; 142: 38894.
  • 7
    Negri E, La Vecchia C, Franceschi S, Levi F, Parazzini F. Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer 1996; 77: 91723.
  • 8
    Jain MG, Rohan TE, Howe GR, Miller AB. A cohort study of nutritional factors and endometrial cancer. Eur J Epidemiol 2000; 16: 899905.
  • 9
    McCann SE, Freudenheim JL, Marshall JR, Brasure JR, Swanson MK, Graham S. Diet in the epidemiology of endometrial cancer in Western New York (United States). Cancer Causes Control 2000; 11: 96574.
  • 10
    Littman AJ, Beresford SAA, White E. The association of dietary fat and plant foods with endometrial cancer (United States). Cancer Causes Control 2001; 12: 691702.
  • 11
    Cancer-preventive effects. In: IARC Handbooks of cancer prevention, vol. 6: weight control and physical activity. Lyon: IARC Press, 2002. p 83206.
  • 12
    Melby CL, Ho RC, Hill JO. Assessment of human energy expenditure. In: BouchardC. Physical activity and obesity. Champaign: Human Kinetics, 2000. p 10331.
  • 13
    Sturgeon SR, Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD. Past and present physical activity and endometrial cancer risk. Br J Cancer 1993; 68: 5849.
  • 14
    Goodman MT, Hankin JH, Wilkens LR, Lyu L-C, McDuffie K, Liu LQ, Kolonel LN. Diet, body size, physical activity, and the risk of endometrial cancer. Cancer Res 1997; 57: 507785.
  • 15
    Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyrén O. Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 1999; 82: 3842.
  • 16
    Moradi T, Weiderpass E, Signorello LB, Persson I, Nyrén O, Adami H-O. Physical activity and postmenopausal endometrial cancer risk (Sweden). Cancer Causes Control 2000; 11: 82937.
  • 17
    Salazar-Martínez E, Lazcano-Ponce EC, Lira-Lira GG, Escudero-De los Ríos P, Salmerón-Castro J, Larrea F, Hernández-Avila M. Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women. Cancer Causes Control 2000; 11: 70711.
  • 18
    Littman AJ, Voigt LF, Beresford SAA, Weiss NS. Recreational physical activity and endometrial cancer risk. Am J Epidemiol 2001; 154: 92433.
  • 19
    Shu XO, Hatch MC, Zheng W, Gao YT, Brinton LA. Physical activity and risk of endometrial cancer. Epidemiology 1993; 4: 3429.
  • 20
    Olson SH, Vena JE, Dorn JP, Marshall JR, Zielezny M, Laughlin R, Graham S. Exercise, occupational activity, and risk of endometrial cancer. Ann Epidemiol 1997; 7: 4653.
  • 21
    Thune I, Brenn T, Lund E, Gaard M. Physical activity and the risk of breast cancer. N Engl J Med 1997; 336: 126975.
  • 22
    Austin H, Austin JM Jr, Partridge EE, Hatch KD, Shingelton HM. Endometrial cancer, obesity, and body fat distribution. Cancer Res 1991; 51: 56872.
  • 23
    Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, et al. Case-control study of endogenous hormones and endometrial cancer. J Natl Cancer Inst 1996; 88: 112735.
  • 24
    Pearl ML, Talavera F, Gretz HF 3rd, Roberts JA, Menon KMJ. Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE. Gynecol Oncol 1993; 49: 32532.
  • 25
    Nagamani M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 1998; 179: 612.
  • 26
    Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 15951607.
  • 27
    Trevisan M, Liu J, Muti P, Misciagna G, Menotti A, Fucci F. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomarkers Prev 2001; 10: 93741.
  • 28
    Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties: Background and organization. Acta Med Scand Suppl 1979; 634: 170.
  • 29
    National Health Screening Service. The cardiovascular disease study in Norwegian counties: results from second screening. Oslo: National Health Screening Service, 1988. 264p.
  • 30
    Vatten LJ, Solvoll K, Løken EB. Coffee consumption and the risk of breast cancer. A prospective study of 14,593 Norwegian women. Br J Cancer 1990; 62: 26770.
  • 31
    Stensvold I, Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 1994; 5: 4018.
  • 32
    Gaard M, Tretli S, Løken EB. Dietary fat and the risk of breast cancer: a prospective study of 25,892 Norwegian women. Int J Cancer 1995; 63: 137.
  • 33
    Veierød MB, Thelle DS, Laake P. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 1997; 71: 6004.
  • 34
    Gaard M, Sandvin O, Løken EB. Calculation of nutrient intake based on dietary data from 2nd cardiovascular disease survey in Finnmark, Sogn og Fjordane, and Oppland 1977–83. Technical report 1. Oslo: The Cancer Registry of Norway, 1994.
  • 35
    Løken EB, Solvoll K. The reproducibility of a self-administered diet questionnaire. Vår Føda 1987; Suppl 1: 337.
  • 36
    Brown ME, Boston MS. Ultra-micro sugar determinations using 2,9-dimethyl-1,10-phenanthroline hydrochloride (Neocuproine). Diabetes 1961; 10: 602.
  • 37
    Terry PD, Miller AB, Rohan TE. A prospective cohort study of cigarette smoking and the risk of endometrial cancer. Br J Cancer 2002; 86: 143035.
  • 38
    Bakken K, Eggen AE, Lund E. Hormone replacement therapy in Norwegian women, 1996−1997. Maturitas 2001; 40: 13141.
  • 39
    Lindström M, Hanson BS, Ö stergren P-O. Socioeconomic differences in leisure-time physical activity: the role of social participation and social capital in shaping health related behaviour. Soc Sci Med 2001; 52: 44151.
  • 40
    Moradi T, Nyrén O, Bergström R, Gridley G, Linet M, Wolk A, Dosemeci M, Adami H-O. Risk of endometrial cancer in relation to occupational physical activity: a nationwide cohort study in Sweden. Int J Cancer 1998; 76: 66570.
  • 41
    Zheng W, Shu XO, McLaughlin JK, Chow W-H, Gao YT, Blot WJ. Occupational physical activity and the incidence of cancer of the breast, corpus uteri, and ovary in Shanghai. Cancer 1993; 71: 36204.
  • 42
    Weiderpass E, Persson I, Adami H-O, Magnusson C, Lindgren A, Baron JA. Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11: 18592.
  • 43
    Rutanen E-M, Stenman S, Blum W, Kärkkäinen T, Lehtovirta P, Stenman U-H. Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls. J Clin Endocrinol Metab 1993; 77: 199204.
  • 44
    Nagamani M, Hannigan EV, Dinh TV, Stuart CA. Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J Clin Endocrinol Metab 1988; 67: 1448.
  • 45
    Troisi R, Potischman N, Hoover RN, Siiteri P, Brinton LA. Insulin and endometrial cancer. Am J Epidemiol 1997; 146: 47682.
  • 46
    Anderson KE, Anderson E, Mink PJ, Hong CP, Kushi LH, Sellers TA, Lazovich D, Folsom AR. Diabetes and endometrial cancer in the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2001; 10: 61116.
  • 47
    Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, Maina A, Chiaffarino F. Diabetes and endometrial cancer: an Italian case-control study. Int J Cancer 1999; 81: 53942.
  • 48
    Shoff SM, Newcomb PA. Diabetes, body size, and risk of endometrial cancer. Am J Epid 1998; 148: 23440.
  • 49
    Hale GE, Hughes CL, Cline JM. Endometrial cancer: Hormonal factors, the perimenopausal “window of risk”, and isoflavones. J Clin Endocrinol Metab 2002; 87: 315.
  • 50
    Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989; 129: 112031.
  • 51
    Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 2001; 12: 4759.
  • 52
    Yu H, Rohan T. Role of the insulin-like growth factor family in cancer development and progression. J Natl Cancer Inst 2000; 92: 147289.
  • 53
    Kritchevsky D. The effect of over- and undernutrition on cancer. Eur J Cancer Prev 1995; 4: 44551.
  • 54
    Gupta K, Krishnaswamy G, Karnad A, Peiris AN. Insulin: A novel factor in carcinogenesis. Am J Med Sci 2002; 323: 1405.
  • 55
    Wilhelmsen L, Tibblin G, Aurell M, Bjure J, Ekström-Jodal B, Grimby G. Physical activity, physical fitness and risk of myocardial infarction. Adv Cardiol 1976; 18: 21730.
  • 56
    Løchen M-L, Rasmussen K. The Tromsø study: physical fitness, self reported physical activity, and their relationship to other coronary risk factors. J Epidemiol Community Health 1992; 46: 1037.
  • 57
    Thune I, Njølstad I, Løchen ML, Førde OH. Physical activity improves the metabolic risk profiles in men and women: the Tromsø Study. Arch Intern Med 1998; 158: 163340.
  • 58
    Backe B, Lilleeng S. Hysterectomy in Norway. Quality of data and clinical practice. Tidsskr Nor Laegeforen 1993; 113: 9714.
  • 59
    Nesheim B-I. Comments on the use of contraceptives. In: Legemiddelforbruket i Norge 1981–1985 [Drug consumption in Norway 1981–1985]. Oslo: Norsk Medisinaldepot [Norwegian Medicinal Depot]. 1986: 1212.